Yanbing Li

22PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)MultimorbidityAutoimmunityMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 26, 2024
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli-D randomized controlled trial.

Ming Liu, Weijun Gu, Li Chen

|May 11, 2022
Prevalence of long-term complications in inpatients with diabetes mellitus in China: a nationwide tertiary hospital-based study.

Yihao Liu, Xin Ning, Luyao Zhang

|Mar 11, 2021
IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy.

Lu Shi, Huijing Ye, Jun Huang

|Jan 08, 2021
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial.

Juming Lu, Liujun Fu, Yan Li

|Dec 08, 2020
Forty-eight weeks of statin therapy for type 2 diabetes mellitus patients with lower extremity atherosclerotic disease: Comparison of the effects of pitavastatin and atorvastatin on lower femoral total plaque areas.

Xieda Zhou, Liting Wu, Yan Chen

|Sep 15, 2020
Screening and the epidemic of thyroid cancer in China: An analysis of national representative inpatient and commercial insurance databases.

Yihao Liu, Fenghua Lai, Jianyan Long

Pageof 4

Frequent Collaborators

9 joint publications

Haipeng Xiao

4 joint publications

Juan Liu

3 joint publications

Yihao Liu

3 joint publications

Hai Li